Evidence map›Paper›PMID 10383973›Full record

ArticleJournal of bacteriology1999

Specific chromosome alterations in fluconazole-resistant mutants of Candida albicans.

V Perepnikhatka, F J Fischer, M Niimi, R A Baker, R D Cannon, Y K Wang, F Sherman, E Rustchenko

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bacteriology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 142 citations in OpenAlex.

  1. Review
  2. Article
  3. Whole-chromosome duplications drive antimicrobial resistance inbioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Selection of Ethanol Tolerant Strains ofbioRxiv : the preprint server for biology · 2023
    Article
  11. Review
  12. Journal of fungi (Basel, Switzerland) · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. mSphere · 2020
    Article
  18. Antibiotics (Basel, Switzerland) · 2020
    Review
  19. Article
  20. Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

V PerepnikhatkaDepartment of Biochemistry and Biophysics, University of Rochester Medical School, Rochester, New York 14642, USA.
F J Fischer
M Niimi
R A Baker
R D Cannon
Y K Wang
F Sherman
E Rustchenko
University of Otago · NZUniversity of Rochester · US

Funding

MOLECULAR BASES OF INTERFERON-INDUCED FUNGISTATISR01AI022963 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HOWARD, DEXTER H · 1986 to 1993
–
NIAID NIH HHS AI22963
6 · The paper itself

Abstract

The exposure of Candida albicans to fluconazole resulted in the nondisjunction of two specific chromosomes in 17 drug-resistant mutants, each obtained by an independent mutational event. The chromosomal changes occurred at high frequencies and were related to the duration of the drug exposure. The loss of one homologue of chromosome 4 occurred after incubation on a fluconazole medium for 7 days. A second change, the gain of one copy of chromosome 3, was observed after exposure for 35 or 40 days. We found that the mRNA levels of ERG11, CDR1, CDR2, and MDR1, the candidate fluconazole resistance genes, remained either the same or were diminished. The lack of overexpression of putative drug pumps or the drug target indicated that some other mechanism(s) may be operating. The fluconazole resistance phenotype, electrophoretic karyotypes, and transcript levels of mutants were stable after growth for 112 generations in the absence of fluconazole. This is the first report to demonstrate that resistance to fluconazole can be dependent on chromosomal nondisjunction. Furthermore, we suggest that a low-level resistance to fluconazole arising during the early stages of clinical treatment may occur by this mechanism. These results support our earlier hypothesis that changes in C. albicans chromosome number is a common means to control a resource of potentially beneficial genes that are related to important cellular functions.

Indexed as

Chromosomes, FungalNondisjunction, GeneticAneuploidyAntifungal AgentsArabinoseCandida albicansDrug Resistance, MicrobialElectrophoresis, Gel, Pulsed-FieldFluconazoleGene DosageKaryotypingMicrobial Sensitivity TestsMutationRNA, BacterialRNA, MessengerSorboseAntifungal AgentsArabinoseFluconazoleRNA, BacterialRNA, MessengerSorbose

Identifiers

PMID10383973
PMCPMC93895
OpenAlexW2100752201

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.